Literature DB >> 23352578

Hyperglycaemia and β-cell antibodies: is it always pre-type 1 diabetes?

Giuseppe d'Annunzio1, Marta Marchi, Concetta Aloi, Alessandro Salina, Francesca Lugani, Renata Lorini.   

Abstract

We describe 10-year-old girl with mild incidental hyperglycaemia, impaired glucose tolerance and GADA positivity. Family history for mild hyperglycaemia and GADA fluctuation alerted us to a possible MODY diagnosis which was confirmed by detection of GCK mutation c.626C>T; p.T209M. Weak or transient β-cell autoimmunity should not preclude genetic testing for MODY when the clinical features are suggestive.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23352578     DOI: 10.1016/j.diabres.2013.01.003

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  3 in total

1.  Autoantibodies and type 1 diabetes: are we still in the cave of an ancient myth?

Authors:  Alfonso Galderisi
Journal:  Diabetologia       Date:  2014-05-17       Impact factor: 10.122

Review 2.  How Recent Advances in Genomics Improve Precision Diagnosis and Personalized Care of Maturity-Onset Diabetes of the Young.

Authors:  Martine Vaxillaire; Philippe Froguel; Amélie Bonnefond
Journal:  Curr Diab Rep       Date:  2019-08-05       Impact factor: 4.810

3.  Maturity-Onset Diabetes of the Young (MODY) in Portugal: Novel GCK, HNFA1 and HNFA4 Mutations.

Authors:  Maria I Alvelos; Catarina I Gonçalves; Eduarda Coutinho; Joana T Almeida; Margarida Bastos; Maria L Sampaio; Miguel Melo; Sofia Martins; Isabel Dinis; Alice Mirante; Leonor Gomes; Joana Saraiva; Bernardo D Pereira; Susana Gama-de-Sousa; Carolina Moreno; Daniela Guelho; Diana Martins; Carla Baptista; Luísa Barros; Mara Ventura; Maria M Gomes; Manuel C Lemos
Journal:  J Clin Med       Date:  2020-01-20       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.